441 related articles for article (PubMed ID: 35729337)
1. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours.
Horbinski C; Berger T; Packer RJ; Wen PY
Nat Rev Neurol; 2022 Sep; 18(9):515-529. PubMed ID: 35729337
[TBL] [Abstract][Full Text] [Related]
2. Major Features of the 2021 WHO Classification of CNS Tumors.
Smith HL; Wadhwani N; Horbinski C
Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
[TBL] [Abstract][Full Text] [Related]
3. The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas.
Park YW; Vollmuth P; Foltyn-Dumitru M; Sahm F; Ahn SS; Chang JH; Kim SH
J Magn Reson Imaging; 2023 Sep; 58(3):690-708. PubMed ID: 37069764
[TBL] [Abstract][Full Text] [Related]
4. WHO 2016 Classification of gliomas.
Wesseling P; Capper D
Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663
[TBL] [Abstract][Full Text] [Related]
5. The 2021 WHO classification of central nervous system tumors: what neurologists need to know.
Jamshidi P; Brat DJ
Curr Opin Neurol; 2022 Dec; 35(6):764-771. PubMed ID: 36226717
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of paediatric central nervous system tumours.
Chiang JC; Ellison DW
J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
[TBL] [Abstract][Full Text] [Related]
7. 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.
McNamara C; Mankad K; Thust S; Dixon L; Limback-Stanic C; D'Arco F; Jacques TS; Löbel U
Neuroradiology; 2022 Oct; 64(10):1919-1950. PubMed ID: 35869291
[TBL] [Abstract][Full Text] [Related]
8. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
9. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract][Full Text] [Related]
10. The Evolving Classification of Diffuse Gliomas: World Health Organization Updates for 2021.
Perez A; Huse JT
Curr Neurol Neurosci Rep; 2021 Nov; 21(12):67. PubMed ID: 34817712
[TBL] [Abstract][Full Text] [Related]
11. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
12. [The 2021 WHO classification of tumours of the central nervous system].
Figarella-Branger D; Appay R; Metais A; Tauziède-Espariat A; Colin C; Rousseau A; Varlet P
Ann Pathol; 2022 Oct; 42(5):367-382. PubMed ID: 34865882
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system.
Gritsch S; Batchelor TT; Gonzalez Castro LN
Cancer; 2022 Jan; 128(1):47-58. PubMed ID: 34633681
[TBL] [Abstract][Full Text] [Related]
14. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
Komori T
Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
[TBL] [Abstract][Full Text] [Related]
15. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
[TBL] [Abstract][Full Text] [Related]
16. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Komori T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
[TBL] [Abstract][Full Text] [Related]
17. 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review.
Thomas DL
Chin Clin Oncol; 2023 Feb; 12(1):7. PubMed ID: 36922356
[TBL] [Abstract][Full Text] [Related]
18. [World Health Organization Classification of Central Nervous System Tumours, 5
Ichimura K
No Shinkei Geka; 2023 Mar; 51(2):349-363. PubMed ID: 37055056
[TBL] [Abstract][Full Text] [Related]
19. Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities.
Wood MD; Halfpenny AM; Moore SR
Diagn Pathol; 2019 Apr; 14(1):29. PubMed ID: 30967140
[TBL] [Abstract][Full Text] [Related]
20. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
Miller DC
Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]